Accueil › Cancer de la prostate › Pennsylvanie › Pittsburgh
Essais cliniques pour Cancer de la prostate à Pittsburgh, PA
23 études pour Cancer de la prostate recherchent des participants dans et autour de Pittsburgh (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recrutement en coursPhase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Recrutement en coursPhase 3
- Allegheny General Hospital, Pittsburgh
- West Penn Hospital, Pittsburgh
- Jefferson Hospital, Jefferson Hills · à 11 mi
- et 3 autres
Distance-Based Exercise to Preserve Function and Prevent Disability
Recrutement en cours
- UPMC Hillman Cancer Center, Pittsburgh
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Recrutement en coursPhase 2
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC-Saint Clair Hospital Cancer Center, Pittsburgh
- et 2 autres
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Recrutement en coursPhase 1
- University of Pittsburgh Medical Center, Pittsburgh
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Recrutement en coursPhase 3
- University of Pittsburgh Medical Center, Pittsburgh
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Recrutement en coursPhase 3
- Research Site, Pittsburgh
Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
Recrutement en coursPhase 1
- University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Recrutement en coursPhase 3
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
- et 6 autres
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Recrutement en coursPhase 3
- Research Site, Pittsburgh
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Recrutement en coursPhase 1
- University of Pittsburgh Medical Center, Pittsburgh
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Recrutement en coursPhase 3
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- et 9 autres
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Recrutement en coursPhase 1
- UPMC Hillman Cancer Center, Pittsburgh
Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
Recrutement en coursPhase 1
- University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Recrutement en coursPhase 1
- University of Pittsburg Medical Center (UPCM), Pittsburgh
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Recrutement en coursPhase 1
- UPMC Hillman Cancer Center, Pittsburgh
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Recrutement en coursPhase 4
- Univ of Pittsburgh Medical Center, Pittsburgh
TERPS Trial for de Novo Oligometastic Prostate Cancer
Recrutement en coursPhase 2
- UPMC Hillman Cancer Center, Pittsburgh
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Recrutement en coursPhase 3
- Allegheny General Hospital, Pittsburgh
- West Penn Hospital, Pittsburgh
- Jefferson Hospital, Jefferson Hills · à 11 mi
- et 2 autres
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Recrutement en coursÉtude observationnelle
- Allegheny Health Network, Pittsburgh
Circulating Tumor DNA in High Risk Localized Prostate Cancer
Recrutement en coursÉtude observationnelle
- UPMC Hillman Cancer Center, Pittsburgh
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Recrutement en coursPhase 3
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
- UPMC-Shadyside Hospital, Pittsburgh
Essais pour Cancer de la prostate dans d'autres villes
- New York City, NY103 études
- Houston, TX76 études
- Los Angeles, CA61 études
- Boston, MA59 études
- St. Louis, MO46 études
- Chicago, IL45 études
- San Francisco, CA45 études
- Philadelphia, PA44 études
- Baltimore, MD43 études
- Nashville, TN42 études
- Seattle, WA42 études
- Washington, DC38 études
Autres études à Pittsburgh
- Cancer du poumon non à petites cellules48 études
- Cancer (tous types)41 études
- Cancer du sein39 études
- Cancer colorectal32 études
- Cancer métastatique31 études
- Mélanome31 études
- Cancer de l'ovaire30 études
- Cancer de l'endomètre23 études
- Cancer du poumon23 études
- Accident vasculaire cérébral22 études
- Carcinome épidermoïde de la tête et du cou22 études
- Dépression22 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.